Vioptix :: Home Vioptix :: Products Vioptix :: Technology Vioptix :: Applications Vioptix :: Company Vioptix :: News Vioptix :: Contact
 

News & Press Releases
8/25/2010
New T.Ox IO Sensor™
9/9/2009
New T.Ox SS Sensor™
6/1/2009
T.Ox™ Clinical Study Published
7/1/2008
ViOptix Relocates to Larger Facility
2/17/2006
Silicon Valley Business Journal: A Scientific Approach to Business..Click to View PDF
1/28/2006
KNTV-NBC 11 News: ViOptix Offers New Hope for Breast Reconstruction Patients..Click to View Video Clip
1/13/2006
East Bay Business Times: The Business of Solving Problems..Click to View PDF
1/1/2006
Today’s Surgicenter:
OR Supersuite features ODISsey™..Click to View PDF
5/21/2008
JACK LLOYD JOINS VIOPTIX BOARD OF DIRECTORS
1/10/2008
VIOPTIX RAISES $12.2 MILLION IN SERIES D FINANCING
3/13/2006
Vioptix Gains ISO Certification for its ODISsey™ Tissue Oximeter, opening Global Markets for Product Platform
1/13/2005
ViOptix Inc. Receives FDA Clearance for ODISsey™ Tissue Oximeter
11/30/2004
ViOptix Inc. Awarded New US Patent
10/29/2004
ViOptix, Inc. Raises $9.2 Million in Funding Round
Contact Us
ViOptix, Inc.
47224 Mission Falls Ct.
Fremont, CA 94539

Tel: 510-226-5860
Fax: 510-226-5864
Email: info@vioptix.com
 

Latest News

 
T.Ox™ Clinical Study Published
By Vioptix
[6/1/2009] The results of a clinical study in the field of plastic and reconstructive surgery where the ViOptix T.Ox Tissue Oximeter was used were recently published in a peer-reviewed journal.

“A New Diagnostic Algorithm for Early Prediction of Vascular Compromise in 208 Microsurgical Flaps Using Tissue Oxygen Saturation Measurements”, Alex Keller, MD, Annals of Plastic Surgery: May 2009, Volume 62, Issue 5, pp. 538-543.

Criteria studied in various combinations were the absolute value of tissue oxygen saturation (StO2), the amount of its change (DStO2) and the rate of its change (DStO2/Dt). 208 flaps were monitored. The new algorithm predicted post-op complications within one hour of the onset of the occlusive event. Five patients exhibited complications predicted by the tissue oximeter before clinical signs were evident.

The investigator concluded that T.Ox facilitates detection of vascular complications before they are clinically apparent; that salvaged flaps should have less fat necrosis because ischemic time can be shortened and no flap being monitored was lost. Click here to view the PubMed Abstract (a link to an external site).
 
home | products | technology | applications | company | news | contact
© 2010, ViOptix Inc. All Rights Reserved.